Cannabinoids and cancer: potential for colorectal cancer therapy
- 1 August 2005
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 33 (4), 712-714
- https://doi.org/10.1042/bst0330712
Abstract
Despite extensive research into the biology of CRC (colorectal cancer), and recent advances in surgical techniques and chemotherapy, CRC continues to be a major cause of death throughout the world. Therefore it is important to develop novel chemopreventive/chemotherapeutic agents for CRC. Cannabinoids are a class of compounds that are currently used in the treatment of chemotherapy-induced nausea and vomiting, and in the stimulation of appetite. However, there is accumulating evidence that they could also be useful for the inhibition of tumour cell growth by modulating key survival signalling pathways. The chemotherapeutic potential for plant-derived and endogenous cannabinoids in CRC therapy is reviewed.Keywords
This publication has 14 references indexed in Scilit:
- Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in GliomasCancer Research, 2004
- A new strategy to block tumor growth by inhibiting endocannabinoid inactivationThe FASEB Journal, 2004
- Cannabinoids: potential anticancer agentsNature Reviews Cancer, 2003
- Possible endocannabinoid control of colorectal cancer growthGastroenterology, 2003
- The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosisCell Death & Differentiation, 2003
- Cannabinoids for gastrointestinal diseases: potential therapeutic applicationsExpert Opinion on Investigational Drugs, 2003
- Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growthThe FASEB Journal, 2001
- Anandamide Induces Apoptosis in Human Cells via Vanilloid ReceptorsJournal of Biological Chemistry, 2000
- Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout MiceScience, 1999
- Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonistBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995